Current research highlights the connection between RA and increased leukemia risk, including shared epigenetic modifications such as ten-eleven translocation 2 (TET2) and DNA methyltransferase 3A (DNMT3A) mutations [17,18]. The gene discussed is TET2; the disease is rheumatoid arthritis.